Drug Profile
Fucoidan-low molecular weight - Fournier
Alternative Names: Low molecular weight fucoidan - FournierLatest Information Update: 08 Jan 2022
Price :
$50
*
At a glance
- Originator Fournier Pharma
- Class Antithrombotics; Polysaccharides
- Mechanism of Action Factor Xa inhibitors; Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 23 Dec 1999 Fucoidan-low molecular weight - Fournier is available for licensing (http://www.groupe-fournier.com/english/)
- 23 Dec 1999 Fucoidan-low molecular weight - Fournier is available for licensing (m.hubert@fournier.fr)
- 08 Jun 1999 Preclinical development for Thrombosis in France (Unknown route)